What Is PEG-MGF?
Mechano Growth Factor (MGF) is a splice variant of IGF-1 produced locally in muscle tissue in response to mechanical loading or damage. The natural form has a half-life of only a few minutes in blood due to rapid enzymatic degradation. PEG-MGF is a modified version where polyethylene glycol chains are attached to the peptide, shielding it from proteases and extending its circulating half-life to several days.
Mechanism of Action
MGF's C-terminal peptide domain activates a distinct receptor pathway from classical IGF-1 signaling. It acts primarily on satellite cells — the muscle stem cells responsible for repair and growth — triggering their proliferation and differentiation into mature myofibers. This action is considered complementary to IGF-1's anabolic effects on existing muscle fibers.
PEGylation Advantage
Natural MGF is produced and acts locally at the site of muscle damage; systemic injection clears before it can reach distant tissues. PEGylation allows systemic delivery with sustained circulatory presence, enabling remote muscle tissue to receive MGF signaling — a research property not achievable with the unmodified peptide.
Research Applications
PEG-MGF is studied in the context of muscle wasting diseases, injury recovery, sarcopenia, and hypertrophy protocols. Preclinical data show enhanced muscle regeneration and preservation of muscle mass during immobilization compared to controls.
Quick Reference
Member reference tables summarize the compound's research parameters.
Research Indications
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below), not a personal dosing recommendation.
This member section describes parameters reported in the research literature.
Peptide Interactions
This member section summarizes reported compound interactions and evidence limitations.
Reported Research Time Points
This member section summarizes reported research time points.
Safety Notes
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
This member section discusses research safety considerations and uncertainties.
Quality Indicators
Research Citations
- Mechano Growth Factor E peptide (MGF-E), derived from an isoform of IGF-1, activates human muscle progenitor cells and induces an increase in their fusion potential at different ages
Kandalla PK, Goldspink G, Butler-Browne G, Mouly V, 2011, Mechanisms of Ageing and Development - Overexpression of Mechano-Growth Factor Modulates Inflammatory Cytokine Expression and Macrophage Resolution in Skeletal Muscle Injury
Doroudian G, Bhomia M, Bhala M, et al., 2018, Frontiers in Physiology - Minireview: Mechano-Growth Factor: A Putative Product of IGF-I Gene Expression Involved in Tissue Repair and Regeneration
Matheny RW Jr, Nindl BC, Adamo ML, 2010, Endocrinology - Mechano-Growth Factor: an important cog or a loose screw in the repair machinery?
Philippou A, Papageorgiou E, Bogdanis G, et al., 2012, Frontiers in Endocrinology - The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration
Dominikowski A, Rękoś Z, Olejarz M, 2026, Front Endocrinol (Lausanne)